Doctors increasingly close doors to drug reps, while pharma cuts ranks
Doctors increasingly close doors to drug reps, while pharma cuts ranks ~ The relationship between doctors and drug reps may never be the same again. Pharmaceutical companies — battered by a sluggish drug pipeline, the looming loss of blockbuster patented drugs, an economy in recession and scrutiny of their relationships with physicians — are re-examining [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
Projecting future drug expenditures–2001
Projecting future drug expenditures–2001 ~ The year 2000 opened to the sound of the general public and politicians focusing on the high cost of drugs and the inability of patients to afford their prescription needs. In an election year, the pharmaceutical industry became an easy target for controversy. Drug cost projections for 2001 and factors [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis ~ Background: Sublingual immunotherapy is well tolerated and data suggest its effectiveness for the treatment of allergic rhinitis in adults, but it lacks optimum dose definition. Objective: To assess the efficacy, safety, and optimal dose of grass [...]
October 25, 2012 | Posted in : Medicine | There’s no comment yet | » read more . . .
A Record Year for the Pharmaceutical Lobby in 2007
A Record Year for the Pharmaceutical Lobby in 2007 ~ Washington’s largest lobby, the pharmaceutical industry, racked up another banner year on Capitol Hill in 2007, backed by a record $168 million lobbying effort, according to a Center for Public Integrity analysis of federal lobbying data. Among the industry’s successes: getting two controversial laws extended [...]
October 25, 2012 | Posted in : Uncategorized | There’s no comment yet | » read more . . .
Drug Companies & Doctors: A Story of Corruption
Drug Companies & Doctors: A Story of Corruption ~ Recently Senator Charles Grassley, ranking Republican on the Senate Finance Committee, has been looking into financial ties between the pharmaceutical industry and the academic physicians who largely determine the market value of prescription drugs. He hasn’t had to look very hard. Take the case of Dr. [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
Personal Use of Drug Samples by Physicians and Office Staff
Personal Use of Drug Samples by Physicians and Office Staff ~ PHARMACEUTICAL companies spend an estimated $10 billion each year on drug promotion in the United States more than $13 000 per physician. Pharmaceutical companies provide free samples to physicians to promote the use of their products. It has been argued that free drug samples [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
THE DRUG PUSHERS
THE DRUG PUSHERS ~ Back in the old days, long before drug companies started making headlines in the business pages, doctors were routinely called upon by company representatives known as “detail men.” To “detail” a doctor is to give that doctor information about a company’s new drugs, with the aim of persuading the doctor to [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
Quality Control Studies on Conventional Carbamazepine Tablets Available on the Turkish Drug Market
Quality Control Studies on Conventional Carbamazepine Tablets Available on the Turkish Drug Market ~ In the drug industry, quality control must be administered in order to prevent the kind of product which is not suitable for the aim, and at the same time it is also necessary for controlling the reliability of the production process. [...]
October 25, 2012 | Posted in : Medicine | There’s no comment yet | » read more . . .
Millions for Viagra, Pennies for Diseases of the Poor
Millions for Viagra, Pennies for Diseases of the Poor ~ Almost three times as many people, most of them in tropical countries of the Third World, die of preventable, curable diseases as die of AIDS. Malaria, tuberculosis, acute lower-respiratory infections in 1998, these claimed 6.1 million lives. People died because the drugs to treat those [...]
October 25, 2012 | Posted in : Health & Medicine | There’s no comment yet | » read more . . .
Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA
Opportunities for Improving the Drug Development Process: Results from a Survey of Industry and the FDA ~ In the United States, the Food and Drug Administration (FDA) agency is responsible for regulating the safety and efficacy of biopharmaceutical drug products. Furthermore, the FDA is tasked with speeding new medical innovations to market. These two missions [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
Drug Makers Raise Prices in Face of Health Care Reform
Drug Makers Raise Prices in Face of Health Care Reform ~ Even as drug makers promise to support Washington’s health care overhaul by shaving $8 billion a year off the nation’s drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years. In the last year, [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease
Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease ~ We sought all clinical trials of memantine vs placebo that included patients with mild AD. The 2 company-sponsored meta-analyses formed the basis for the search. We relied on the formal searches for memantine clinical trials of AD that we conducted for the [...]
October 25, 2012 | Posted in : Drug Abuse | There’s no comment yet | » read more . . .
